Does DARBEPOETIN ALFA Cause Hyperlipidaemia? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Hyperlipidaemia have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.2% of all adverse event reports for DARBEPOETIN ALFA.
55
Reports of Hyperlipidaemia with DARBEPOETIN ALFA
0.2%
of all DARBEPOETIN ALFA reports
55
Deaths
52
Hospitalizations
How Dangerous Is Hyperlipidaemia From DARBEPOETIN ALFA?
Of the 55 reports, 55 (100.0%) resulted in death, 52 (94.5%) required hospitalization, and 51 (92.7%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which DARBEPOETIN ALFA Alternatives Have Lower Hyperlipidaemia Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE